Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183M
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
72.5M
-
Shares change
-
+12M
-
Total reported value, excl. options
-
$2B
-
Value change
-
+$345M
-
Put/Call ratio
-
0.88
-
Number of buys
-
96
-
Number of sells
-
-59
-
Price
-
$27.60
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q1 2018
190 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q1 2018.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.5M shares
of 183M outstanding shares and own 39.58% of the company stock.
Largest 10 shareholders include FMR LLC (10.6M shares), JANUS HENDERSON GROUP PLC (8.02M shares), FRANKLIN RESOURCES INC (7.04M shares), BAKER BROS. ADVISORS LP (5.03M shares), BlackRock Inc. (3.51M shares), STATE STREET CORP (3.14M shares), VANGUARD GROUP INC (2.8M shares), ArrowMark Colorado Holdings LLC (2.37M shares), WELLINGTON MANAGEMENT GROUP LLP (2.17M shares), and EAGLE ASSET MANAGEMENT INC (1.81M shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.